Phase 2 Haemophilia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are male and have been diagnosed with hemophilia B
- You are 18 years of age or older
- Your Factor IX (the clotting protein affected in hemophilia B) level is 2% or less, and you do not have inhibitors (antibodies that block the treatment) (confirm with trial site)
- You have received Factor IX treatment products on at least 150 separate days in the past
Who may not be able to join:
- You have previously received any type of gene therapy
- You have another blood or bone marrow disorder in addition to hemophilia B
- You have certain antibodies in your blood that could interfere with the trial treatment (confirm with trial site)
- You have HIV that is not being successfully controlled with antiviral medication
- You have hepatitis B or active/chronic hepatitis C infection (confirm with trial site for which parts of the trial this applies to)
- You currently have an active infection throughout your body, or you frequently get infections that need systemic (whole-body) treatment
- You have any other condition that seriously weakens your immune system
- You have significant liver disease, such as liver cirrhosis or liver scarring (fibrosis)
- You have had a cancer diagnosis and have been in remission for less than 5 years
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Arina V Zinkina-Orikhan, MD, Director of Clinical Development Department, BIOCAD
Phone: +7 (812) 380 49 34
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in FIX activity from baseline; Proportion of subjects with adverse reactions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.